RA

Ron Alfa

North America, Utah, United States, Salt Lake City

Description

Ron Alfa is the Co-Founder and CEO at Oncology StealthCo.

Investor Profile

Ron Alfa has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ron Alfa frequently co-invest with?

Playground Global
North America, California, United States, Palo Alto
Co-Investments: 1
Pear VC
North America, California, United States, Menlo Park
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Axial VC
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Ron Alfa often collaborate with?

JB
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
JM
North America, California, United States, Newport Beach
Shared Deals: 1
BK
North America, California, United States, Stanford
Shared Deals: 1
PC
North America, California, United States, Palo Alto
Shared Deals: 1

What are some of recent deals done by Ron Alfa?

Infinimmune

San Francisco, California, United States

Infinimmune operates as a biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
SeedDec 6, 2022
Amount Raised: $12,000,000